Delivery Order SPE2DB24D1104-SPE2DB25FYCF7

Award Date 6/19/25
Potential Completion Date 6/20/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,566,025 units of the drug febuxostat 40 mg tablets. The delivery order contract, valued at $1,624.68, has a firm fixed price and an ultimate completion date of October 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of febuxostat 40 mg tablets. The contract has a firm fixed price, with a ceiling value of $1,273.48, and a period of performance ending on June 23, 2025. The contract is not set aside and was awarded on June 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,008.52, is for the delivery of Febuxostat 80mg tablets to support federal healthcare programs. The contract has a period of performance through March 31, 2025 and uses a firm fixed price pricing structure. This award is a task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,661,577 units of febuxostat 40 mg tablets. The award, valued at $2,066.16, is a Firm Fixed Price Delivery Order with an ultimate completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization registered in the System for Award Management...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,296,599 units of Febuxostat 40 mg Tablets in 30-count packages. The contract has a ceiling value of $1,928.52 and is a Firm Fixed Price arrangement. It was awarded on July 30, 2024 with a performance period through July 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, to provide FEBUXOSTAT 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $1,138.50 and an ultimate completion date of July 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication FEBUXOSTAT 40 MG TABLET 30S and has a ceiling value of $1,848.50. It is a firm fixed price delivery order contract with a completion date of May 23, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of febuxostat 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,075.98 and an ultimate completion date of April 14, 2025. There was no set-aside designation for this award. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of FEBUXOSTAT 40 MG TABLET 30S. The contract has a firm fixed price of $1,372.43 and a completion date of June 10, 2025. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including DLA. The contract is not set aside...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FAMN5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,802.68 firm fixed-price delivery order is for the supply of 4567201573 - FEBUXOSTAT 40 MG TABLET 30S, with a completion date of February 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FYCF7
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Febuxostat 80 mg tablets. The fixed-price delivery order has a ceiling value of $1,224.27 and a period of performance through June 20, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp has a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/18/25, 10:52 AM